• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1995 Fiscal Year Final Research Report Summary

Genetic analysis of cerebrotendinous xanthomatosis

Research Project

Project/Area Number 06044070
Research Category

Grant-in-Aid for international Scientific Research

Allocation TypeSingle-year Grants
SectionJoint Research
Research InstitutionUniversity of Tokyo

Principal Investigator

SEYAMA Yousuke  University of Tokyo, Faculty of Medicine, Professor, 医科部(医), 教授 (90010082)

Co-Investigator(Kenkyū-buntansha) EGGERTSEN Goesta  Karolinska Institute, Huddinge University Hospital, Lecturer, 講師
BJOERKHEM Ingemar  Karolinska Institute, Huddinge University Hospital, Professor, 教授
KURIMOTO Masaru  Fukui Medical School, Professor, 医学部, 教授 (80107870)
KUBOTA Shunichiro  University of Tokyo, Faculty of Medicine, Associate Professor, 医科部(医), 助教授 (00260480)
YONEMOTO Kyozo  Jikei University School of Medicine, Professor, 医学部, 教授 (80056572)
Project Period (FY) 1994 – 1995
KeywordsCTX / CYP27 Gene / Cholestanol / Point Mutation / Non-RI-PCR-SSCP / RNase Protection Assay / CDCA / Pravastatin / LDL-apheresis
Research Abstract

1) Identification of novel mutation in CTX patient : The underlying biochemical defect of cerebrotendinous xanthomatosis (CTX) is a lack of sterol 27-hydroxylase, which leads to the accumulation of cholestanol in several tissues. We investigated a 44-year-old Japanese male CTX patient. Non-RI-PCR-SSCP method was applied to analyze the CYP 27 gene. Abnormally migrating bands of the patient indicated that a mutation exists within and/or around exon 7. Direct sequence analysis was conducted and new two point mutations at codon 397 [GTG (Val) to GGT (Gly)] at the heme ligand binding region of the CYP 27 were identified.
2) RNase protection assay of CYP 27mRNA : Then we adopted an RNase protection assay which is expected to identify the CYP27 mRNA more specifically and sensitively. (1) CYP27cDNA (nt 675-958) was amplified by PCR and an Eco RI and Bam HI digested fragment of the CYP27cDNA was isolated and subcloned into the pBluescript II SK+vector. (2) The plasmid was linearized by Eco RI di … More gestion. ^<32>P-labeled anti-sense RNA (cDNA) was prepared by transcription of the DNA with T3 RNA polymerase with the exixtence of ^<32>P-labeled nucleotides. (3) RNA was extracted from human liver and human rhabdomyosarcoma cells. ^<32>P-labeled probe was hybridized with 15 mg of RNA.Unhybridized regions were digested by the RNase T1 and RNase A treatment. (4) Samples were loaded on the sequence gel. The bands of expected size were confirmed compared with the DNA size marker. Human g actin mRNA was detected in both liver and RD cells, but CYP27 mRNA was detected only in liver. For the purpose of CTX diagnosis, it is necessary to improve the sensitivity to detect mRNA using human fibroblast.
3) Treatment of CTX patient : Atherosclerosis is one of the major symptoms in CTX.We applied pravastatin treatment together with CDCA administration The progression of disease was arrested, but dramatic effects on clinical manifestations, xanthoma, and electrophysiological findings could not be found after the treatment of these drug. Less

  • Research Products

    (10 results)

All Other

All Publications (10 results)

  • [Publications] Wengen Chen,Shunichiro Kubota,Yukiko Nishimura,Shuichi Nozaki,Shizuya Yamashita,Tsutomu Nakagawa,Kaoru Kameda-Takemura,Masakazu Menju,Yuji Matsuzawa,Ingemar Bjoerkhem,Goesta Eggertsen,and Yousuke Seyama: "Genetic Analysis on a Japanese Cerebrotendinous Xanthomatosis Family : identification of novel mutation in adrenodoxin binding region of CYP 27 gene" J.of Lipid Research.

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 程錦雁,久保田俊一郎,西村友紀子,金慶淑,栗山勝,米本恭三,Ingemar Bjoerkhem,広澤一成,脊山洋右: "脳腱黄色腫症における遺伝子異常" 生化学. 66. 719 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 西村友紀子,久保田俊一郎,陳文根,程錦雁,寺本民生,Ingemar Bjoerkhem,脊山洋右: "脳腱黄色腫症における遺伝子異常" 生化学. 67. 814 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Wen-Neng Chang,M.Kuriyama,E.C.-Y.Chee: "Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid in three siblings" J.Formos.Med.Assoc.93. 256-259 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] M.Kuriyama,Y.Tokimura,J.Fujiyama,Y.Utatsu,M.Osame: "Treatment of cerebrotendinous xanthomatosis effects of chenodeoxycholic acid pravastatin,and combined use" J.Neurol.Sci.125. 22-28 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] M.Kuriyama,Y.Mimura: "LDL-apheresis in cerebrotendinous xanthomatosis : reply to the letter by Berginer and Salen" J.Neurol.Sci.121. 229-230 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Wengen Chen, Shunichiro Kubota, Yukiko Nishimura, Shuichi Nozaki, Shizuya Yamashita, Tsutomu Nakagawa, Kaoru Kameda-Takemura, Masakazu Menju, Yuji Matsuzawa, Ingemar Bjoerkhem, Goesta Eggertsen, and Yousuke Seyama: "Genetic Analysis on a Japanese Cerebrotendinous Xanthomatosis Family : identification of novel mutation in adrenodoxin binding region of CYP 27 gene" J.of Lipid Research.

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Wen-Neng Chang, M.Kuriyama, E.C.-Y.Chee: "Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid in three siblings" J.Formos. Med.Assoc.93. 256-259 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] M.Kuriyama, Y.Tokimura, J.Fujiyama, Y.Utatsu, M.Osame: "Treatment of cerebrotendinous xanthomatosis effects of chenodeoxycholic acid pravastatin, and combined use" J.Neurol.Sci.125. 22-28 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] M.Kuriyama, Y.Mimura: "LDL-apheresis in cerebrotendinous xanthomatosis : reply to the letter by Berginer and Salen" J.Neurol.Sci.121. 229-230 (1994)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1997-03-04   Modified: 2017-10-10  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi